Abstract
Inflammation as a result of NF-κB activation may result from the classical (canonical) pathway, with disconnection of the IκB inhibitor and subsequent nuclear translocation or, alternatively, by post-translational modifications of modulatory proteins or NF-κB subunits (non-canonical pathway). We hypothesized that hyperglycemia-induced increased glycosylation with O-linked N-acetylglucosamine (O-GlcNAc) of NF-κB in placental tissue leads to augmented production of pro-inflammatory cytokines, culminating in placental dysfunction and fetal restriction growth. Single injections of streptozotocin (40 mg/kg) or vehicle were used to induce hyperglycemia or normoglycemia, respectively, in female Wistar rats. After 3 days, rats were mated and pregnancy confirmed. Placental tissue was collected at 21 days of pregnancy. Placental expression of p65 subunit was similar between groups. However, nuclear translocation of p65 subunit, showing greater activation of NF-κB, was increased in the hyperglycemic group. Reduced expression of IκB and increased expression of phosphorylated IκBSer32 were observed in the placenta from hyperglycemic rats, demonstrating increased classical NF-κB activation. Augmented modification of O-GlcNAc-modified proteins was found in the placenta from hyperglycemic rats and p65 subunit was a key O-GlcNAc target, as demonstrated by immunoprecipitation. Tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) expressions were increased in the placenta from hyperglycemic rats. Furthermore, placental weight was increased, whereas fetal weight was decreased under hyperglycemic conditions. TNF-α and IL-6 demonstrated positive correlations with placental weight and negative correlations with fetal weight and placental efficiency. Therefore, under hyperglycemic conditions, a modulatory role of O-GlcNAc in NF-κB activity was demonstrated in the placenta, contributing to fetal and placental dysfunction due to inflammatory cytokine exacerbation.
Similar content being viewed by others
References
Desoye, G., and Hauguel-de Mouzon S. 2007. The human placenta in gestational diabetes mellitus: The insulin and cytokine network. Diabetes Care 30: 120–126.
Huynh, Q.K., H. Boddupalli, S.A. Rouw, C.M. Koboldt, T. Hall, C. Sommers, et al. 2000. Characterization of the recombinant IKK1 / IKK2 heterodimer. The Journal of Biological Chemistry 275: 25883–25891.
Pantham, P., I.L.M.H. Aye, and T.L. Powell. 2015. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta 36: 709–715.
Moreli, J.B., A.M.C. Ruocco, J.M. Vernini, M.V.C. Rudge, and I.M.P. Calderon. 2011. Interleukin 10 and tumor necrosis factor-alpha in pregnancy: Aspects of interest in clinical obstetrics. ISRN Obstetrics and Gynecology 2012: 1–5.
Oztas, E., K. Erkenekli, S. Ozler, A. Aktas, and U. Buyukkagn. 2015. First trimester interleukin-6 levels help to predict adverse pregnancy outcomes in both thyroid autoantibody positive and negative patients. Journal of Obstetrics and Gynaecology Research 41: 1700–1707.
Vaughan, J.E., and S.W. Walsh. 2012. Activation of NF-kB in placentas of women with preeclampsia. Hypertension in Pregnancy 31: 243–251.
Lai, J., Y. Liu, C. Liu, M. Qi, R. Liu, X. Zhu, et al. 2016. Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-kB and MAPK signaling pathways. Inflammation 1–12.
Yang, W.H., S.Y. Park, H.W. Nam, D.H. Kim, J.G. Kang, E.S. Kang, et al. 2008. NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proceedings of the National Academy of Sciences 105: 17345–17350.
Laczy, B., B.G. Hill, K. Wang, A.J. Paterson, C.R. White, D. Xing, et al. 2009. Protein O-GlcNAcylation: A new signaling paradigm for the cardiovascular system. American Journal of Physiology. Heart and Circulatory Physiology 296: 13–28.
Lima, V.V., K. Spitler, H. Choi, R.C. Webb, and R.C. Tostes. 2012. O-GlcNAcylation and oxidation of proteins: Is signalling in the cardiovascular system becoming sweeter? Clinical Science 486: 473–486.
Ahmed, S., E.N. Mundh, M. Borgohain, L. Chowdhury, M. Kwatra, N. Bolshette, et al. 2016. Diosmin modulates the NF-kB signal transduction pathways and downregulation of various oxidative stress markers in alloxan-induced diabetic nephropathy. Inflammation 39: 1783–1797.
Baudoin, L., and T. Issad. 2014. O-GlcNAcylation and inflammation: A vast territory to explore. Frontiers in Endocrinology 5: 1–8.
Agca, C.A., M. Tuzcu, A. Hayirli, and K. Sahin. 2014. Taurine ameliorates neuropathy via regulating NF-kB and Nrf2/HO-1 signaling cascades in diabetic rats. Food and Chemical Toxicology 71: 116–121.
Bowie, A., and L.A.J.O. Neill. 2000. Oxidative stress and nuclear factor kappa B activation. Biochemical Pharmacology 59: 13–23.
Drougat, L., Olivier-Van Stichelen S., M. Mortuaire, F. Foulquier, A.S. Lacoste, J.C. Michalski, et al. 2012. Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition. Biochimica et Biophysica Acta 1820: 1839–1848.
Frank, L.A., M.L. Sutton-McDowall, H.M. Brown, D.L. Russell, R.B. Gilchrist, and J.G. Thompson. 2014. Hyperglycemic conditions perturb mouse oocyte in vitro developmental competence via beta-O-linked glycosylation of heat shock protein 90. Human Reproduction 29: 1292–1303.
Phoomak, C., Kulthida, V., Kanlayanee, S., Wunchana, S., Chaisiri, W., Atit, S., Sopit, W. 2016. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB. Scientific Reports p.1–12.
Viatour, P., M. Merville, V. Bours, and A. Chariot. 2005. Phosphorylation of NF-kB and IkB proteins: Implications in cancer and inflammation. Trends in Biochemical Sciences 30: 43–52.
Liu, K., A.J. Paterson, E. Chin, and J.E. Kudlow. 2000. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: Linkage of O-linked GlcNAc to beta cell death. Proceedings of the National Academy of Sciences 97: 2820–2825.
Akimoto, Y., H. Kawakami, K. Yamamoto, E. Munetomo, T. Hida, and H. Hirano. 2003. Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats. Investigative Ophthalmology & Visual Science 44: 3802–3809.
Marshall, S., O. Nadeau, and K. Yamasaki. 2004. Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: Differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels. The Journal of Biological Chemistry 279: 35313–35319.
Yki-Järvinen, H., A. Virkamäki, M.C. Daniels, D. McClain, and W.K. Gottschalk. 1998. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism 47: 449–455.
Vermeulen, L., D.W. Gerte, V.D. Petra, V.B. Wim, and H. Guy. 2003. Transcriptional activation of the NF-k B p65 subunit by mitogen- and stress-activated protein kinase-1. EMBO Journal 22: 1313–1324.
Chen, L.F., W. Fischle, E. Verdin, and W.C. Greene. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293: 1653–1657.
James, L.R., et al. Flux through the hexosamine pathway is a determinant of nuclear fator kB-dependent promoter activation. Diabetes 51: 146–1156.
Hu, P., S. Shimoji, and G.W. Hart. 2010. Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation. FEBS Letters 584: 2526–2538.
Comer, F.I., and W.H. Gerald. 2000. O-Glycosylation of nuclear and cytosolic proteins. The Journal of Biological Chemistry 275: 29179–29182.
Gao, Y., W. Lance, I.C. Frank, J.P. Glendon, and W.H. Gerald. 2001. Dynamic O-glycosylation of nuclear and cytosolic proteins: Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. Journal of Biological Chemistry 276: 9838–9845.
Ramakrishnan, P., M.C. Peter, E.M. Daniel, C.P. Eric, C.H. Linda, and B. David. 2013. Activation of the transcriptional function of the NF-kappaB protein c-Rel by O-GlcNAc glycosylation. Science Signaling. Immunology 6: 1–13.
Kirwan, J.P., S.H. Mouzon, J. Lepercq, J. Challier, L. Huston-presley, J.E. Friedman, et al. 2002. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51: 2207–2213.
Hauguel-de Mouzon, S., and M. Guerre-Millo. 2006. The placenta cytokine network and inflammatory signals. Placenta 27: 794–798.
Higgins, M., and F. Mc Auliffe. 2010. A review of maternal and fetal growth factors in diabetic pregnancy. Current Diabetes Reviews 6: 116–125.
Damasceno, D.C., Y.K. Sinzato, A. Bueno, A.O. Netto, B. Dallaqua, F.Q. Gallego, et al. 2013. Mild diabetes models and their maternal-fetal repercussions. Journal of Diabetes Research 2013: 1–9.
Sinzato, Y.K., G.T. Volpato, I.L. Iessi, A. Bueno, I. De Mattos, P. Calderon, et al. 2012. Neonatally induced mild diabetes in rats and its effect on maternal, placental and fetal parameters. Experimental Diabetes Research 2012: 1–7.
Zhou, J., X. Ni, X. Huang, J. Yao, Q. He, K. Wang, et al. 2016. Potential role of hyperglycemia in fetoplacental endothelial dysfunction in gestational diabetes mellitus. Cellular Physiology and Biochemistry 39: 1317–1328.
Acknowledgments
This study was supported by the Fundação de Amparo à Pesquisa do Estado de Mato Grosso (FAPEMAT, 151371/2014 to F.R.G.; 211997/2015 to V.V.L.), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, 23038009165/2013-48 to V.V.L.), and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, 471675/2013-0 and 305823/2015-9 to F.R.G; 445777/2014-1 to V.V.L.).
Author Contribution Statement
VDJ, JSG, and RAF performed the molecular experiments. VDJ and ADF conducted cytokine measurements. VDJ, FRG, and VVL performed the statistical analysis. FRG designed the hypothesis. RCT, FSC, VVL, and FRG provided the financial support, supervised the study, and continuously contributed with ideas and expertise for the project and revisions for the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures were performed in accordance with the Guiding Principles in the Care and Use of Animals, approved by the Ethics Committee on Animal Research (CEUA) of the Federal University of Mato Grosso (23108.120946/2015-83).
Conflict of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Dela Justina, V., Gonçalves, J.S., de Freitas, R.A. et al. Increased O-Linked N-Acetylglucosamine Modification of NF-ΚB and Augmented Cytokine Production in the Placentas from Hyperglycemic Rats. Inflammation 40, 1773–1781 (2017). https://doi.org/10.1007/s10753-017-0620-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-017-0620-7